Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

AI-driven OCT imaging system enables precise wound healing assessment

23

Mar 2026

AI-driven OCT imaging system enables precise wound healing assessment

No matter the size or severity, wounds on human skin are difficult to monitor while they heal. Biopsies disrupt the wound site and are too invasive for routine, repeated monitoring, and most medical imaging devices that could do the job are large, expensive and booked up with more pressing diagnostics.

Early adulthood hypertension linked to heart and kidney disease later in life

23

Mar 2026

Early adulthood hypertension linked to heart and kidney disease later in life

Higher blood pressure during young adulthood is likely linked to a higher risk of heart disease and kidney disease later in life, reinforcing the importance of maintaining healthy blood pressure at younger ages, according to preliminary research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026.

New NYU study identifies lower heat risk thresholds for vulnerable older adults

23

Mar 2026

New NYU study identifies lower heat risk thresholds for vulnerable older adults

Nationally, heat-related mortality has risen by nearly 17 % per year since 2016. As a result, New York City now issues heat alerts and opens cooling centers when the heat index is forecast to reach 95 degrees Fahrenheit or higher for at least two consecutive days or a heat index of 100 degrees Fahrenheit or higher for any length of time.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.